Diagnostic Performance of Loop-Mediated Isothermal Amplification and Ultrasensitive Rapid Diagnostic Tests for Malaria Screening Among Pregnant Women in Kenya

Abstract Background Screen-and-treat strategies with sensitive diagnostic tests may reduce malaria-associated adverse pregnancy outcomes. We conducted a diagnostic accuracy study to evaluate new point-of-care tests to screen pregnant women for malaria at their first antenatal visit in western Kenya....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of infectious diseases 2022-09, Vol.226 (4), p.696-707
Hauptverfasser: Samuels, Aaron M, Towett, Oliver, Seda, Brian, Wiegand, Ryan E, Otieno, Kephas, Chomba, Miriam, Lucchi, Naomi, Ljolje, Dragan, Schneider, Kammerle, Walker, Patrick G T, Kwambai, Titus K, Slutsker, Laurence, ter Kuile, Feiko O, Kariuki, Simon K
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract Background Screen-and-treat strategies with sensitive diagnostic tests may reduce malaria-associated adverse pregnancy outcomes. We conducted a diagnostic accuracy study to evaluate new point-of-care tests to screen pregnant women for malaria at their first antenatal visit in western Kenya. Methods Consecutively women were tested for Plasmodium infection by expert microscopy, conventional rapid diagnostic test (cRDT), ultra sensitive RDT (usRDT), and loop-mediated isothermal amplification (LAMP). Photoinduced electron-transfer polymerase chain reaction (PET-PCR) served as the reference standard. Diagnostic performance was calculated and modelled at low parasite densities. Results Between May and September 2018, 172 of 482 screened participants (35.7%) were PET-PCR positive. Relative to PET-PCR, expert microscopy was least sensitive (40.1%; 95% confidence interval [CI], 32.7%–47.9%), followed by cRDT (49.4%; 95% CI, 41.7%–57.1), usRDT (54.7%; 95% CI, 46.9%–62.2%), and LAMP (68.6%; 95% CI, 61.1%–75.5%). Test sensitivities were comparable in febrile women (n = 90). Among afebrile women (n = 392), the geometric-mean parasite density was 29 parasites/µL and LAMP (sensitivity = 61.9%) and usRDT (43.2%) detected 1.74 (95% CI, 1.31–2.30) and 1.21 (95% CI, 88–2.21) more infections than cRDT (35.6%). Per our model, tests performed similarly at densities >200 parasites/µL. At 50 parasites/µL, the sensitivities were 45%, 56%, 62%, and 74% with expert microscopy, cRDT, usRDT, and LAMP, respectively. Conclusions This first-generation usRDT provided moderate improvement in detecting low-density infections in afebrile pregnant women compared to cRDTs. Most pregnant women in sub-Saharan Africa have low parasite densities and are asymptomatic when screened for Plasmodium falciparum at their first antenatal care visit. The first-generation usRDT provide detect 21% more low-density infections in afebrile pregnant women compared to cRDTs.
ISSN:0022-1899
1537-6613
1537-6613
DOI:10.1093/infdis/jiac289